Astellas, Drugs for Neglected Diseases initiative (DNDi) deal

Astellas partnered with DNDi to evaluate the pharma's compounds as potential therapies for leishmaniasis, Chagas disease and human African trypanosomiasis. DNDi will conduct reprofiling of the compoun...